Researcher.Life Logo

Personalized Medicine : Impact Factor & More

eISSN: 1744-828XpISSN: 1741-0541

Key Metrics

CiteScore
3.5
Impact Factor
< 5
SJR
Q3Pharmacology
SNIP
0.67
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Personalized Medicine

Personalized Medicine Journal Specifications

Overview
Publisher FUTURE MEDICINE LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2004
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Personalized Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Personalized Medicine

Prevalence and correlates of pharmacotherapy metabolized by CYP2C19, CYP2C9, CYP2D6, and UGT1A1 in the population sample
  • 21 Apr 2026
  • Personalized Medicine
Integrating host genetics in Helicobacter pylori infection: clinical insights for personalized eradication strategies.
  • 16 Apr 2026
  • Personalized medicine
Assessment of exonic polymorphism of IDH2, KRAS1, TP53, and BRAF2 using PCR-RFLP in hepatocellular carcinoma: a case-control study from Arunachal Pradesh and Sikkim.
  • 13 Apr 2026
  • Personalized medicine
From genomes to metabolomes: adaptive science in personalized medicine.
  • 13 Apr 2026
  • Personalized medicine
An integrated triple approach - TPMT phenotype, NUDT-15 genotype, and therapeutic drug monitoring of thiopurine metabolites for optimal clinical efficacy: a case series.
  • 13 Apr 2026
  • Personalized medicine
Association of a common SOD gene variant with ARHL risk: analysis by age, hearing threshold, and enzyme activity.
  • 10 Apr 2026
  • Personalized medicine
Prevalence and correlates of pharmacotherapy metabolized by CYP2C19, CYP2C9, CYP2D6, and UGT1A1 in the population sample
  • 21 Apr 2026
  • Personalized Medicine
Integrating host genetics in Helicobacter pylori infection: clinical insights for personalized eradication strategies.
  • 16 Apr 2026
  • Personalized medicine
Assessment of exonic polymorphism of IDH2, KRAS1, TP53, and BRAF2 using PCR-RFLP in hepatocellular carcinoma: a case-control study from Arunachal Pradesh and Sikkim.
  • 13 Apr 2026
  • Personalized medicine
From genomes to metabolomes: adaptive science in personalized medicine.
  • 13 Apr 2026
  • Personalized medicine
An integrated triple approach - TPMT phenotype, NUDT-15 genotype, and therapeutic drug monitoring of thiopurine metabolites for optimal clinical efficacy: a case series.
  • 13 Apr 2026
  • Personalized medicine
Association of a common SOD gene variant with ARHL risk: analysis by age, hearing threshold, and enzyme activity.
  • 10 Apr 2026
  • Personalized medicine

FAQs on Personalized Medicine